BIOCAD is one of the largest innovative biotech companies in Russia. It brought together world-class R&D centers, modern pharmaceutical and biotechnological production, and preclinical and clinical trials, compliant with international standards.
BIOCAD is a full-cycle drug development company, from molecule search to mass production and marketing support. The drugs are intended for the treatment of oncological and autoimmune diseases. Present product portfolio includes 60 medical products, more than 20 are biological. Over 40 products are now in different development stages. Development of drugs for cancer therapy is one of the priorities of the company.
There are 2700 people working in BIOCAD, more than 30% are scientists and researchers. Offices of the company are located in Brazil, China, Vietnam, UAE and other countries.